Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.
Global Medical REIT Inc., now Chiron Real Estate Inc., reports developments for a net-lease medical REIT that owns healthcare facilities leased to physician groups and regional and national healthcare systems. Company news centers on financial results, earnings calls, dividend declarations and tax treatment for common and preferred stock, and capital-structure actions involving preferred securities and indebtedness.
Updates also cover governance changes, shareholder voting matters, and the completed rebrand from Global Medical REIT to Chiron Real Estate, including the related ticker change and continuity of REIT qualification, organizational structure and stockholder rights.
Global Medical REIT (NYSE: GMRE) announced its 2023 first quarter cash dividends for common and preferred shares. The common cash dividend is set at $0.21 per share, payable on April 11, 2023, to stockholders of record as of March 24, 2023. Additionally, the Series A preferred dividend is $0.46875 per share, to be paid on May 1, 2023, for shareholders on record as of April 15, 2023. This reflects the company's ongoing commitment to return value to shareholders through consistent dividends.
Global Medical REIT (NYSE: GMRE) reported its financial results for 2022, revealing a 19.6% year-over-year increase in total revenue to $36.3 million in Q4 and $137.3 million for the year. Net income attributable to common stockholders for Q4 was $0.4 million ($0.01 per diluted share) compared to $3.8 million ($0.06 per diluted share) in the prior year. Full-year net income rose to $13.3 million ($0.20 per share) versus $11.8 million ($0.19 per share) previously. The company completed 14 acquisitions totaling $149 million. Rental revenue increased 19.7% to $36.3 million in Q4, despite total expenses climbing to $34.5 million.
Global Medical REIT Inc. (NYSE: GMRE) will release its fourth quarter and year-end 2022 financial results on February 28, 2023, after market close. A conference call to discuss these results is scheduled for March 1, 2023, at 9:00 a.m. ET. The call will feature key executives including Chairman and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the call via a live webcast on the Company’s website, with a replay available from 12:00 p.m. ET on March 1 until midnight on March 15, 2023.
Global Medical REIT Inc. (NYSE: GMRE) recently updated its shareholders on the federal income tax treatment of the dividends paid in 2022. The relevant information has been made available on the Company's website. Shareholders are advised to review their 2022 Forms 1099 and consult with tax advisors regarding their specific tax implications. GMRE is a net-lease medical office REIT that focuses on acquiring specialized healthcare facilities and leasing them to major healthcare systems and physician groups.
Global Medical REIT (NYSE: GMRE) announced that Pipeline Health will assume its leases at the White Rock Medical Center in Dallas as part of its bankruptcy reorganization. The new lease structure will not affect cash rents, rental rates per square foot, or lease terms. Proposed amendments allow GMRE to provide up to $3.8 million for capital expenditures, with $3.1 million expected to increase future rents. Pipeline must also pay any pre-petition rents owed as of October 2022. The outcome of this bankruptcy process is seen as favorable for GMRE, reinforcing its investment strategy in the Dallas market.
Global Medical REIT Inc. (NYSE: GMRE) announced its fourth-quarter 2022 dividends, declaring a cash dividend of $0.21 per common share, payable on January 9, 2023, to shareholders of record as of December 22, 2022. Additionally, a quarterly cash dividend of $0.46875 per share on its Series A Preferred Stock will be paid on January 31, 2023, to preferred stockholders of record as of January 15, 2023. This announcement signals the company's ongoing commitment to returning value to its shareholders.
Global Medical REIT Inc. (NYSE: GMRE) invested $51 million in medical real estate during Q3 2022, raising its total investments to $149 million for the year. The company achieved a net income of $8.1 million ($0.12 per diluted share), up from $3.7 million ($0.06) YoY. Revenue increased 18.1% to $35.4 million, driven by acquisitions. The company secured a $150 million term loan, locking in 80% of its debt at fixed rates. Occupancy stands at 97%, reflecting portfolio strength. Dividends for the third quarter were declared at $0.21 per share.
Global Medical REIT Inc. (NYSE: GMRE) announced it will release its third quarter 2022 financial results on November 2, 2022, after the market closes. A conference call to discuss these results is scheduled for November 3, 2022, at 9:00 a.m. Eastern Time. The call will feature key executives including Jeffrey Busch, Robert Kiernan, and Alfonzo Leon. Investors can access the call via a live webcast or by dialing in. Replay options will be available post-call.
Global Medical REIT (NYSE: GMRE) has declared its 2022 third quarter cash dividend of $0.21 per share for common stock, payable on October 11, 2022. The ex-dividend date is September 23, 2022. Additionally, a cash dividend of $0.46875 per share on its Series A Preferred Stock is scheduled for payment on October 31, 2022, with a record date of October 15, 2022. GMRE focuses on acquiring specialized healthcare facilities and leasing them to prominent healthcare systems.
Global Medical REIT (NYSE: GMRE) reported a net income of $2.2 million or $0.03 per diluted share for Q2 2022, down from $2.6 million or $0.04 per diluted share year-on-year. Funds from Operations (FFO) rose to $16.4 million ($0.24/share), up from $14.1 million ($0.22/share) in Q2 2021. Total revenue increased by 19.2% to $33.7 million due to acquisition activity. The company acquired properties worth $74 million and amended its credit facility to add a $150 million term loan. As of June 30, 2022, portfolio occupancy stood at 96.5%. The company declared a dividend of $0.21 per share for Q2 2022.